JCI - Citations to Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

Citations to this article

Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

P A Von dem Borne, … , M E Nesheim, B N Bouma

P A Von dem Borne, … , M E Nesheim, B N Bouma

Published May 15, 1997
Citation Information: J Clin Invest. 1997;99(10):2323-2327. https://doi.org/10.1172/JCI119412.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	Total
Citations:	1	4	2	2	5	1	10	5	7	1	5	7	4	9	11	4	9	6	9	5	5	11	9	7	10	2	5	156

Citation information

Citations to this article (156)

Title and authors	Publication	Year
Laboratory and Molecular Diagnosis of Factor XI Deficiency Davidson S, Gomez K	Seminars in Thrombosis and Hemostasis	2024
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis. Akbulut AC, Arisz RA, Baaten CCFMJ, Baidildinova G, Barakzie A, Bauersachs R, Ten Berg J, van den Broek WWA, de Boer HC, Bonifay A, Bröker V, Buka RJ, Ten Cate H, Ten Cate-Hoek AJ, Cointe S, De Luca C, De Simone I, Diaz RV, Dignat-George F, Freson K, Gazzaniga G, van Gorp ECM, Habibi A, Henskens YMC, Iding AFJ, Khan A, Koenderink GH, Konkoth A, Lacroix R, Lahiri T, Lam W, Lamerton RE, Lorusso R, Luo Q, Maas C, McCarty OJT, van der Meijden PEJ, Meijers JCM, Mohapatra AK, Nevo N, Robles AP, Poncelet P, Reinhardt C, Ruf W, Saraswat R, Schönichen C, Schutgens R, Simioni P, Spada S, Spronk HMH, Tazhibayeva K, Thachil J, Diaz RV, Vallier L, Veninga A, Verhamme P, Visser C, Watson SP, Wenzel P, Willems RAL, Willers A, Zhang P, Zifkos K, van Zonneveld AJ	Thrombosis and haemostasis	2023
Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study. Paszek E, Polak M, Bryk-Wiązania AH, Konieczyńska M, Undas A	Cardiovascular Diabetology	2023
Targeting factor XI and factor XIa to prevent thrombosis Gailani D, Gruber A	Blood	2023
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis. Goel A, Tathireddy H, Wang SH, Vu HH, Puy C, Hinds MT, Zonies D, McCarty OJT, Shatzel JJ	Seminars in thrombosis and hemostasis	2023
VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow van Moorsel MV, Poolen GC, Koekman CA, Verhoef S, de Maat S, Barendrecht A, van Kleef ND, Meijers JC, Schiffelers RM, Maas C, Urbanus RT	Journal of Thrombosis and Haemostasis	2022
Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis. Mochizuki L, Sano H, Honkura N, Masumoto K, Urano T, Suzuki Y	Thrombosis and haemostasis	2022
Emerging agents for the treatment and prevention of stroke: progress in clinical trials A Safouris, G Magoufis, G Tsivgoulis	Expert Opinion on Investigational Drugs	2021
Negatively charged phospholipids stimulate factor XI activation by thrombin F Omarova, J Rosing, RM Bertina, E Castoldi		2021
Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques Y Asada, A Yamashita, Y Sato, K Hatakeyama	Pathology International	2020
How to Capture the Bleeding Phenotype in FXI-Deficient Patients DB Calderara, MG Zermatten, A Aliotta, L Alberio	Hämostaseologie	2020
Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy DB Calderara, MG Zermatten, A Aliotta, AP Sauvage, V Carle, C Heinis, L Alberio	Thrombosis and Haemostasis	2020
Heterozygote carriers of mutations in the F11 gene, encoding Factor XI, have normal coagulation by thromboelastography during pregnancy EJ Ciampa, N Liu, J Stiles, JL Carani, Y Li, PE Hess	International Journal of Obstetric Anesthesia	2020
From multi-target anticoagulants to DOACs, and intrinsic coagulation factor inhibitors L Lin, L Zhao, N Gao, R Yin, S Li, H Sun, L Zhou, G Zhao, SW Purcell, J Zhao	Blood Reviews	2020
Hydrogen‐deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XI a AB Barroeta, J Galen, I Stroo, JA Marquart, AB Meijer, JC Meijers	Journal of Thrombosis and Haemostasis	2019
Thrombus Formation and Propagation in the Onset of Cardiovascular Events Y Asada, A Yamashita, Y Sato, K Hatakeyama	Journal of Atherosclerosis and Thrombosis	2018
Structural basis for the selective inhibition of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) by a selenium-containing inhibitor with chloro-aminopyridine as a basic group T Itoh, N Yoshimoto, Y Hirano, K Yamamoto	Bioorganic & Medicinal Chemistry Letters	2018
Prochemerin processing by factor XIa JC Meijers	Blood	2018
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency GN Gidley, LA Holle, J Burthem, PH Bolton-Maggs, FC Lin, AS Wolberg	Blood Advances	2018
Blood coagulation dissected EL Pryzdial, FM Lee, BH Lin, RL Carter, TZ Tegegn, MJ Belletrutti	Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis	2018
Improving the understanding of plasma kallikrein contribution to arterial thrombus formation using two plant protease inhibitors BR Salu, SC Pando, MV Brito, AF Medina, F Odei-Addo, C Frost, R Naude, MU Sampaio, J Emsley, FH Maffei, ML Oliva	Platelets	2018
Successful perioperative management in a patient with factor XI deficiency ML McCarthy, SM Ordway, RM Jones, JG Perkins	BMJ case reports	2018
Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity RL Carter, K Talbot, WS Hur, SC Meixner, JG Gugten, DT Holmes, HC Côté, CJ Kastrup, TW Smith, AY Lee, EL Pryzdial	Journal of Thrombosis and Haemostasis	2018
Three strikes to a hemophilic joint bleed T Lisman	Blood	2018
Inherited Bleeding Disorders in Women 2e R Kadir		2018
The Effects of the Contact Activation System on Hemorrhage F Simão, EP Feener	Frontiers in Medicine	2017
Platelets in Thrombotic and Non-Thrombotic Disorders P Gresele, NS Kleiman, JA Lopez, CP Page	Platelets in Thrombotic and Non-Thrombotic Disorders	2017
Cardio-Nephrology J Rangaswami, EV Lerma, C Ronco	Cardio-Nephrology	2017
Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency GN Pike, AM Cumming, J Thachil, CR Hay, PH Bolton-Maggs, J Burthem	Haemophilia : the official journal of the World Federation of Hemophilia	2017
Perioperative management of rare coagulation factor deficiency states in cardiac surgery ER Strauss, MA Mazzeffi, B Williams, NS Key, KA Tanaka	British Journal of Anaesthesia	2017
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway M Colucci, F Incampo, A Cannavò, M Menegatti, SM Siboni, F Zaccaria, N Semeraro, F Peyvandi	Journal of Thrombosis and Haemostasis	2016
Is resistance futile? The role of activated thrombin-activatable fibrinolysis inhibitor resistance in bleeding in factor XI deficiency MB Boffa	Journal of Thrombosis and Haemostasis	2016
Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules T Plug, JC Meijers	Thrombosis Research	2016
Understanding cardiovascular risk in hemophilia: A step towards prevention and management N Sousos, E Gavriilaki, S Vakalopoulou, V Garipidou	Thrombosis Research	2016
Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin JL Sylman, U Daalkhaijav, Y Zhang, EM Gray, PA Farhang, TT Chu, J Zilberman-Rudenko, C Puy, EI Tucker, SA Smith, JH Morrissey, TW Walker, XL Nan, A Gruber, OJ McCarty	Annals of Biomedical Engineering	2016
Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation: Q Ding, L Yang, X Zhao, W Wu, X Wang, AR Rezaie	Thrombosis and Haemostasis	2016
Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events M Preis, J Hirsch, A Kotler, A Zoabi, N Stein, G Rennert, W Saliba	Blood	2016
Factor XI and contact activation as targets for antithrombotic therapy D Gailani, CE Bane, A Gruber	Journal of Thrombosis and Haemostasis	2015
Allosteric Inhibition of Human Factor XIa: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors MD Argade, AY Mehta, A Sarkar, UR Desai	Journal of Medicinal Chemistry	2014
Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene M Kong, Y Kim, C Lee	Molecular Biology Reports	2014
Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency M Zucker, U Seligsohn, O Salomon, AS Wolberg	Journal of Thrombosis and Haemostasis	2014
The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure A Alam, C Cserti-Gazdewich, J Pendergrast	Canadian Journal of Anesthesia/Journal canadien d'anesthésie	2014
Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology AD Mumford, S Ackroyd, R Alikhan, L Bowles, P Chowdary, J Grainger, J Mainwaring, M Mathias, N O'Connell	British Journal of Haematology	2014
Proteolytic modulation of factor Xa–antithrombin complex enhances fibrinolysis in plasma K Talbot, SC Meixner, EL Pryzdial	Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics	2013
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis F Incampo, C Carrieri, R Galasso, FA Scaraggi, FD Serio, B Woodhams, N Semeraro, M Colucci	Journal of Thrombosis and Haemostasis	2013
Elevated plasma factor VIII enhances venous thrombus formation in rabbits: Contribution of factor XI, von Willebrand factor and tissue factor: C Sugita, A Yamashita, Y Matsuura, T Iwakiri, N Okuyama, S Matsuda, T Matsumoto, O Inoue, A Harada, T Kitazawa, K Hattori, M Shima, Y Asada	Thrombosis and Haemostasis	2013
Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model: ML van Montfoort, VL Knaup, JA Marquart, K Bakthiari, FJ Castellino, CE Hack, JC Meijers	Thrombosis and Haemostasis	2013
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots: CT Ammollo, F Semeraro, M Colucci, P Simioni	Thrombosis and Haemostasis	2013
Down-regulation of the clotting cascade by the protein C pathway F Stavenuiter, EA Bouwens, LO Mosnier		2013
Structural Basis for Inhibition of Carboxypeptidase B by Selenium-Containing Inhibitor: Selenium Coordinates to Zinc in Enzyme N Yoshimoto, T Itoh, Y Inaba, H Ishii, K Yamamoto	Journal of Medicinal Chemistry	2013
Management of Gynecologic Surgery in the Patient With Factor XI Deficiency : A Review of the Literature RG Steward, OA Saleh, AH James, AA Shah, TM Price	Obstetrical & Gynecological Survey	2012
Factor XIII and Tranexamic Acid But Not Recombinant Factor VIIa Attenuate Tissue Plasminogen Activator–Induced Hyperfibrinolysis in Human Whole Blood : D Dirkmann, K Görlinger, C Gisbertz, F Dusse, J Peters	Anesthesia & Analgesia	2012
Evidence that fibrinolytic changes in paediatric obesity translate into a hypofibrinolytic state: Relative contribution of TAFI and PAI-1 F Semeraro, P Giordano, MF Faienza, L Cavallo, N Semeraro, M Colucci	Thrombosis and Haemostasis	2012
Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins S Chtourou, M Poulle	Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins	2012
Pathogenesis and Pathophysiology of Pneumococcal Meningitis BB Mook-Kanamori, M Geldhoff, T van der Poll, D van de Beek	Clinical microbiology reviews	2011
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood C Carrieri, R Galasso, F Semeraro, CT Ammollo, N Semeraro, M Colucci	Journal of Thrombosis and Haemostasis	2011
Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events A Undas, A Slowik, M Gissel, KG Mann, S Butenas	European Journal of Clinical Investigation	2011
Factor XI deficiency R Santoro, S Prejanò, P Iannaccaro	Blood Coagulation & Fibrinolysis	2011
Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid O Panes, O Padilla, V Matus, CG Sáez, A Berkovits, J Pereira, D Mezzano	Platelets	2011
Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events A Undas, A Slowik, M Gissel, KG Mann, S Butenas	Thrombosis Research	2011
Polyphosphate is a cofactor for the activation of factor XI by thrombin SH Choi, SA Smith, JH Morrissey	Blood	2011
Thrombin activatable fibrinolysis inhibitor: At the nexus of fibrinolysis and inflammation M Colucci, N Semeraro	Thrombosis Research	2011
Coronary artery stenting in a patient with factor XI deficiency B Kaku, M Shimojima, T Yoshida, S Katsuda, T Taguchi, Y Nitta, C Sugimori, Y Hiraiwa	Cardiovascular Intervention and Therapeutics	2011
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma C Maas, JC Meijers, JA Marquart, K Bakhtiari, C Weeterings, PG de Groot, RT Urbanus	Proceedings of the National Academy of Sciences	2010
Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis M Takahashi, A Yamashita, S Moriguchi-Goto, C Sugita, T Matsumoto, S Matsuda, Y Sato, T Kitazawa, K Hattori, M Shima, Y Asada	Thrombosis Research	2010
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution D Bolliger, K Görlinger, KA Tanaka	Anesthesiology	2010
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk H Zhang, EC Lowenberg, JR Crosby, AR MacLeod, C Zhao, D Gao, C Black, AS Revenko, JC Meijers, ES Stroes, M Levi, BP Monia	Blood	2010
ORIGINAL RESEARCH: Thrombin-activatable fibrinolysis inhibitor activity in healthy and diseased dogs LR Jessen, B Wiinberg, M Kjelgaard-Hansen, AL Jensen, E Rozanski, AT Kristensen	Veterinary Clinical Pathology	2010
Coagulation factor XI as a novel target for antithrombotic treatment EC Löwenberg, JC Meijers, BP Monia, M Levi	Journal of Thrombosis and Haemostasis	2010
Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy M Zabczyk, S Butenas, I Palka, J Nessler, A Undas	Polskie Archiwum Medycyny Wewnetrznej	2010
Tratado de Medicina Transfusional Perioperatoria A Oliver, P Sierra	Tratado de Medicina Transfusional Perioperatoria	2010
Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum D Li, Q He, T Kang, H Yin, X Jin, H Li, W Gan, C Yang, J Hu, Y Wu, L Peng	Biochemical and Biophysical Research Communications	2010
Platelet Factor 4 Inhibits Thrombomodulin-dependent Activation of Thrombin-activatable Fibrinolysis Inhibitor (TAFI) by Thrombin LO Mosnier	The Journal of biological chemistry	2010
Molecular Characterization of FXI Deficiency E Berber	Clinical and Applied Thrombosis/Hemostasis	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Factor XI deficiency--resolving the enigma? PH Bolton-Maggs	Hematology	2009
Dual modulation of prothrombin activation by the cyclopentapeptide plactin T Harada, T Tsuruta, K Yamagata, T Inoue, K Hasumi	FEBS Journal	2009
Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2) TC White-Adams, MA Berny, EI Tucker, JM Gertz, D Gailani, RT Urbanus, PG de Groot, A Gruber, OJ McCarty	Arteriosclerosis, thrombosis, and vascular biology	2009
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI EI Tucker, UM Marzec, TC White, S Hurst, S Rugonyi, OJ McCarty, D Gailani, A Gruber, SR Hanson	Blood	2008
Fundamental and Clinical Cardiology Series PD Stein	Cardiovascular Disease in the Elderly	2008
Effects of ascorbic acid on coagulation during living donor liver transplantation in adults BS Shin, BD Lee, TS Hahm, CS Kim, CD Park, MS Gwak, SM Lee, IS Chung, GS Kim	Korean Journal of Anesthesiology	2008
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency O Salomon, DM Steinberg, N Koren-Morag, D Tanne, U Seligsohn	Blood	2008
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency NM O'connell, AF Riddell, G Pascoe, DJ Perry, CA Lee	Haemophilia	2008
Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation T Taketomi, F Szlam, SO Bader, CA Sheppard, JH Levy, KA Tanaka	Blood Coagulation & Fibrinolysis	2008
Transfusion packages for massively bleeding patients: The effect on clot formation and stability as evaluated by Thrombelastograph (TEG®) PI Johansson, L Bochsen, J Stensballe, NH Secher	Transfusion and Apheresis Science	2008
Assessment of Fibrinolytic Activity by Measuring the Lysis Time of a Tissue Factor-induced Clot: A Feasibility Evaluation AP Cellai, D Lami, A Magi, AA Liotta, A Rogolino, E Antonucci, B Bandinelli, R Abbate, D Prisco	Clinical and Applied Thrombosis/Hemostasis	2008
Antibodies with Dual Reactivity to Plasminogen and Complementary PR3 in PR3-ANCA Vasculitis DJ Bautz, GA Preston, S Lionaki, P Hewins, AS Wolberg, JJ Yang, SL Hogan, H Chin, S Moll, JC Jennette, RJ Falk	Journal of the American Society of Nephrology : JASN	2008
The intrinsic pathway of coagulation: a target for treating thromboembolic disease? D Gailani, T Renné	Journal of Thrombosis and Haemostasis	2007
Investigation of the thrombin-generating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 days PI Johansson, MS Svendsen, J Salado, L Bochsen, AT Kristensen	Vox Sanguinis	2007
Feedback activation of factor XI by thrombin does not occur in plasma DL Pedicord, D Seiffert, Y Blat	Proceedings of the National Academy of Sciences	2007
Curiouser and curiouser: Recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles M Boffa, M Koschinsky	Clinical Biochemistry	2007
Thrombophilia: Clinical and Laboratory Assessment and Management JA Heit	Consultative Hemostasis and Thrombosis	2007
Consultative Hemostasis and Thrombosis VJ Marder	Consultative Hemostasis and Thrombosis	2007
Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis? BN Bouma, LO Mosnier	Annals of Medicine	2006
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) RM Bertina, NH van Tilburg, F Haverkate	Journal of Thrombosis and Haemostasis	2006
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice X Wang, PL Smith, MY Hsu, D Gailani, WA Schumacher, ML Ogletree, DA Seiffert	Journal of Thrombosis and Haemostasis	2006
Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor PA von Borne, LM Cox, BN Bouma	Blood Coagulation & Fibrinolysis	2006
Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery A Yamashita, K Nishihira, T Kitazawa, K Yoshihashi, T Soeda, K Esaki, T Imamura, K Hattori, Y Asada	Journal of Thrombosis and Haemostasis	2006
TAFI and PAI-1 levels in human sepsis S Zeerleder, V Schroeder, CE Hack, HP Kohler, WA Wuillemin	Thrombosis Research	2006
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII CJ Doggen, FR Rosendaal, JC Meijers	Blood	2006
Mechanism of action, development and clinical experience of recombinant FVIIa U Hedner	Journal of Biotechnology	2006
Study of Association Between Hypertensive Disorders of Pregnancy and the Human Coagulation Factor XI Gene I Sato, T Nakayama, A Maruyama, K Furuya, N Sato, Y Mizutani, T Yamamoto	Hypertension in Pregnancy	2006
Treatment of factor XI inhibitor using recombinant activated factor VIIa MM Bern, M Sahud, O Zhukov, K Qu, W Mitchell	Haemophilia	2005
The discovery of TAFI M Nesheim, L Bajzar	Journal of Thrombosis and Haemostasis	2005
Modulation of TAFI function through different pathways - implications for the development of TAFI inhibitors A Gils, E Ceresa, AM Macovei, PF Marx, M Peeters, G Compernolle, PJ Declerck	Journal of Thrombosis and Haemostasis	2005
Studies in Multidisciplinarity CH Toh	Studies in Multidisciplinarity	2005
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis T Lisman, PG de Groot, JC Meijers, FR Rosendaal	Blood	2005
Tissue factor and tissue factor pathway inhibitor GC Price, SA Thompson, PC Kam	Anaesthesia	2004
New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R) BN Bouma, JC Meijers	Seminars in Hematology	2004
Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease? JP Antovic, S Schulman, SS An, RS Greenfield, M Blombäck	Scandinavian Journal of Clinical & Laboratory Investigation	2004
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism M Colucci, BM Binetti, A Tripodi, V Chantarangkul, N Semeraro	Blood	2004
Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism S Eichinger, V Schönauer, A Weltermann, E Minar, C Bialonczyk, M Hirschl, B Schneider, P Quehenberger, PA Kyrle	Blood	2004
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux T Lisman, NR Bijsterveld, J Adelmeijer, JC Meijers, M Levi, HK Nieuwenhuis, PG de Groot	Journal of Thrombosis and Haemostasis	2003
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) BN Bouma, JC Meijers	Journal of Thrombosis and Haemostasis	2003
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) at the Interface between Coagulation and Fibrinolysis BN Bouma, LO Mosnier	Pathophysiology of Haemostasis and Thrombosis	2003
Inherited factor XI deficiency confers no protection against acute myocardial infarction O Salomon, DM Steinberg, R Dardik, N Rosenberg, A Zivelin, I Tamarin, B Ravid, S Berliner, U Seligsohn	Journal of Thrombosis and Haemostasis	2003
Eptifibatide-induced thrombocytopenia and coronary bypass operation KA Tanaka, JD Vega, AB Kelly, SR Hanson, JH Levy	Journal of Thrombosis and Haemostasis	2003
Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis MD Vannorsdall, YS Arkel, DH Ku, FL Lucas, J Himmelfarb	Kidney International	2003
Plasmatic coagulation and fibrinolytic system alterations in PNH M Grünewald, A Siegemund, A Grünewald, A Schmid, M Koksch, C Schöpflin, S Schauer, M Griesshammer	Blood Coagulation & Fibrinolysis	2003
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis T Lisman, PG de Groot	Journal of Thrombosis and Haemostasis	2003
Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor: T Lisman, J Adelmeijer, HK Nieuwenhuis, PG de Groot	Blood Coagulation & Fibrinolysis	2003
Thrombin and Fibrinolysis M Nesheim	Chest	2003
Stabilization Versus Inhibition of TAFIa by Competitive Inhibitors in Vitro JB Walker, B Hughes, I James, P Haddock, C Kluft, L Bajzar	The Journal of biological chemistry	2003
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life Mariko Nagashima, Zheng-Feng Yin, Lei Zhao, Kathy White,Yanhong Zhu, Nina Lasky, Meredith Halks-Miller, George J. Broze, Jr., William P. Fay, John Morser	Journal of Clinical Investigation	2002
In Vivo Regulation of the Functions of Plasminogen by Plasma Carboxypeptidase B Carmen M. Swaisgood, Detlef Schmitt, Dan Eaton, Edward F. Plow	Journal of Clinical Investigation	2002
Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia M Grunewald, A Siegemund, A Grunewald, A Konegen, M Koksch, M Griesshammer	Haemophilia	2002
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII JP Antovic, A Antovic, S He, L Tengborn, M Blomback	Haemophilia	2002
Effects of ximelagatran, the oral form of melagatran, in the treatment of caval vein thrombosis in conscious rats S Carlsson, M Elg, C Mattsson	Thrombosis Research	2002
Enhanced endogenous thrombolysis induced by a specific factor Xa inhibitor, DX-9065a, evaluated in a rat arterial thrombolysis model in vivo M Hashimoto, Y Onobayashi, K Oiwa, JC Giddings, J Yamamoto	Thrombosis Research	2002
Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation T Lisman	Hepatology	2002
Studies on the Different Modes of Action of the Anticoagulant Protease Inhibitors DX-9065a and Argatroban: II. EFFECTS ON FIBRINOLYSIS H Nagashima	The Journal of biological chemistry	2002
The Sepsis Text JL Vincent, J Carlet, SM Opal		2002
Fast Homogeneous Assay for Plasma Procarboxypeptidase U KA Schatteman, FJ Goossens, J Leurs, Y Kasahara, SS Scharpé, DF Hendriks	Clinical Chemistry and Laboratory Medicine	2001
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever EC van Gorp, MC Minnema, C Suharti, AT Mairuhu, DP Brandjes, H Cate, CE Hack, JC Meijers	British Journal of Haematology	2001
Factor IX and thrombosis GD Lowe	British Journal of Haematology	2001
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI, Plasma Procarboxypeptidase B, Procarboxypeptidase R, Procarboxypeptidase U) BN Bouma, PF Marx, LO Mosnier, JC Meijers	Thrombosis Research	2001
Fisiopatología de la hemostasia. Mecanismos de activación e inhibición. Implicaciones funcionales RM Díaz, JH Santos, AP Ruiz, VH Linares	Medicine - Programa de Formación Médica Continuada Acreditado	2001
Treatment of Iatrogenic Femoral Pseudoaneurysms with Percutaneous Thrombin Injection: Experience in 54 Patients1 RG Sheiman, DP Brophy	Radiology	2001
Overview of Blood Coagulation D Green	Hemodialysis International	2001
Coagulation problems in liver disease SI Rapaport	Blood Coagulation & Fibrinolysis	2000
Role of blood coagulation factor XI in downregulation of fibrinolysis BN Bouma, JC Meijers	Current Opinion in Hematology	2000
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia JC Meijers, EJ Oudijk, LO Mosnier, R Bos, BN Bouma, HK Nieuwenhuis, R Fijnheer	British Journal of Haematology	2000
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis JC Meijers, WL Tekelenburg, BN Bouma, RM Bertina, FR Rosendaal	New England Journal of Medicine	2000
An Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor Potentiates Tissue-Type Plasminogen Activator-Induced Thrombolysis in a Rabbit Jugular Vein Thrombolysis Model M Nagashima, M Werner, M Wang, L Zhao, DR Light, R Pagila, J Morser, P Verhallen	Thrombosis Research	2000
Consequences of inhibition of plasma carboxypeptidase B on in vivo thrombolysis, thrombosis and hemostasis CJ Refino, L DeGuzman, D Schmitt, R Smyth, S Jeet, MT Lipari, D Eaton, S Bunting	Fibrinolysis and Proteolysis	2000
Tissue factor pathway of coagulation in sepsis: CE Hack	Critical Care Medicine	2000
Activation of Clotting Factors XI and IX in Patients With Acute Myocardial Infarction MC Minnema, RJ Peters, R de Winter, YP Lubbers, S Barzegar, KA Bauer, RD Rosenberg, CE Hack, H ten Cate	Arteriosclerosis, thrombosis, and vascular biology	2000
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway L Bajzar	Arteriosclerosis, thrombosis, and vascular biology	2000
Modulation of hemostatic mechanisms in bacterial infectious diseases H Tapper, H Herwald	Blood	2000
Identification of a novel mutation in a non-Jewish factor XI deficient kindred A Alhaq, M Mitchell, M Sethi, S Rahman, G Flynn, P Boulton, G Caeno, M Smith, G Savidge	British Journal of Haematology	1999
TAFI ME Nesheim	Fibrinolysis and Proteolysis	1999
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation P Gresele, S Momi, M Berrettini, GG Nenci, HP Schwarz, N Semeraro, M Colucci	Journal of Clinical Investigation	1998
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor MC Minnema, PW Friederich, M Levi, PA von Borne, LO Mosnier, JC Meijers, BJ Biemond, CE Hack, BN Bouma, H Cate	Journal of Clinical Investigation	1998
Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant PG Groot, DA Horbach, MJ Simmelink, EV Oort, RH Derksen	Lupus	1998
Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor L Bajzar, M Nesheim, J Morser, PB Tracy	The Journal of biological chemistry	1998
Activation of Clotting Factor XI Without Detectable Contact Activation in Experimental Human Endotoxemia MC Minnema, D Pajkrt, WA Wuillemin, D Roem, WK Bleeker, M Levi, SJ van Deventer, CE Hack, H ten Cate	Blood	1998

Advertisement